For the current week, the overall ratings of six Medical Devices stocks are worse, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
This week, Synergetics USA (NASDAQ:SURG) falls to a D (“sell”), worse than last week’s grade of C (“hold”). Synergetics USA develops and manufactures medical devices and products for the hospital and healthcare communities. In Portfolio Grader’s specific subcategories of Earnings Momentum and Earnings Surprise, SURG also gets F’s. Shares of the company are down 5.7% from last month. This is worse than the 5.2% increase for the Nasdaq for the same period. For a full analysis of SURG stock, visit Portfolio Grader.
Alere‘s (NYSE:ALR) rating falls this week to an F (“strong sell”), down from last week’s D (“sell”) last week. Alere develops and manufactures patient diagnosis, monitoring, and health management products and services for cardiology, infectious diseases, toxicology, diabetes, oncology, and womens health in the United States and internationally. The stock gets F’s in Earnings Momentum and Equity. Over the last month, the price of ALR has declined 4%. For more information, get Portfolio Grader’s complete analysis of ALR stock.
This is a rough week for Staar Surgical (NASDAQ:STAA). The company’s rating falls to D from the previous week’s C. Staar Surgical develops, manufactures, and markets high margin visual implants that improve a patient’s quality of vision. The stock also rates an F in Earnings Revisions. The stock currently has a trailing PE Ratio of 637. To get an in-depth look at STAA, get Portfolio Grader’s complete analysis of STAA stock.
The rating of Hansen Medical (NASDAQ:HNSN) declines this week from a D to an F. Hansen Medical develops and manufactures medical robotics designed for positioning, manipulation, and control of catheters and catheter-based technologies. The stock receives F’s in Earnings Growth, Earnings Momentum, and Equity. Cash Flow and Sales Growth also get F’s. The stock price has dropped 12.9% over the past month. As of Aug. 20, 16.4% of outstanding Hansen Medical shares were held short. For a full analysis of HNSN stock, visit Portfolio Grader.
AtriCure‘s (NASDAQ:ATRC) rating weakens this week, dropping to an F versus last week’s D. AtriCure engages in developing, manufacturing, and selling cardiac surgical ablation systems designed to create precise lesions or scars in cardiac tissue in the United States and internationally. The stock also gets an F in Equity. Share prices fell 18.5% over the past month. For more information, get Portfolio Grader’s complete analysis of ATRC stock.
NxStage Medical (NASDAQ:NXTM) earns an F this week, falling from last week’s grade of D. NxStage Medical is medical device company that develops, manufactures, and markets systems for the treatment of end-stage renal disease and acute kidney failure. The stock also rates an F in Equity. Over the last month, the stock price has fallen 13.7%. As of Aug. 20, 12.5% of outstanding NxStage Medical shares were held short. To get an in-depth look at NXTM, get Portfolio Grader’s complete analysis of NXTM stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.